FDA Inspection 1201009 — LifeShare Blood Center
The FDA completed an inspection of LifeShare Blood Center on Mar 10, 2023 in Bossier City, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 10, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Bossier City, LA (United States)